70
Participants
Start Date
September 21, 2017
Primary Completion Date
October 7, 2020
Study Completion Date
October 7, 2020
Ruxolitinib phosphate cream
Ruxolitinib phosphate cream at the protocol-defined dose strength based on cohort assignment.
Penn State Hershey Medical Center, Hershey
Wake Research Associates Llc, Raleigh
Iact Health, Columbus
Acevedo Clinical Research, Miami
Floridian Research Institute Llc, Miami
Rm Medical Research Inc, Miami
Olympian Clinical Research, Tampa
Olympian Clinical Research, Largo
Cahaba Dermatology, Hoover
Ohio Pediatric Research Association, Dayton
The Indiana Clincal Trials Center, Plainfield
David Fivenson, Md, Pllc, Ann Arbor
Northwestern University, Chicago
Applied Research Center of Arkansas, Little Rock
Progressive Clinical Research, San Antonio
Texas Dermatology and Laser Specialists, San Antonio
National Jewish Health, Denver
Advanced Clinical Research, Boise
Desert Sky Dermatology, Gilbert
Children'S Hospital Los Angeles Specialt, Los Angeles
Rady Children'S Hospital - San Diego, San Diego
Orange County Research Center, Anaheim
Cyn3Rgy Research - Clinedge - Ppds, Gresham
Lead Sponsor
Incyte Corporation
INDUSTRY